|
Name |
ergosterol-3-O-β-D-glucopyranoside
|
Molecular Formula | C34H54O6 | |
IUPAC Name* |
2-[[17-(5,6-dimethylhept-3-en-2-yl)-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
|
|
SMILES |
CC(C)C(C)C=CC(C)C1CCC2C3=CC=C4CC(OC5OC(CO)C(O)C(O)C5O)CCC4(C)C3CCC21C
|
|
InChI |
InChI=1S/C34H54O6/c1-19(2)20(3)7-8-21(4)25-11-12-26-24-10-9-22-17-23(13-15-33(22,5)27(24)14-16-34(25,26)6)39-32-31(38)30(37)29(36)28(18-35)40-32/h7-10,19-21,23,25-32,35-38H,11-18H2,1-6H3/b8-7+/t20-,21+,23-,25+,26?,27?,28?,29?,30?,31?,32?,33-,34+/m0/s1
|
|
InChIKey |
MKZPNGBJJJZJMI-USHFEQKUSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 558.8 | ALogp: | 5.2 |
HBD: | 4 | HBA: | 6 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 99.4 | Aromatic Rings: | 5 |
Heavy Atoms: | 40 | QED Weighted: | 0.31 |
Caco-2 Permeability: | -4.797 | MDCK Permeability: | 0.00005120 |
Pgp-inhibitor: | 0.908 | Pgp-substrate: | 0.036 |
Human Intestinal Absorption (HIA): | 0.167 | 20% Bioavailability (F20%): | 0.007 |
30% Bioavailability (F30%): | 0.273 |
Blood-Brain-Barrier Penetration (BBB): | 0.223 | Plasma Protein Binding (PPB): | 99.63% |
Volume Distribution (VD): | 1.925 | Fu: | 2.03% |
CYP1A2-inhibitor: | 0.002 | CYP1A2-substrate: | 0.134 |
CYP2C19-inhibitor: | 0.005 | CYP2C19-substrate: | 0.948 |
CYP2C9-inhibitor: | 0.016 | CYP2C9-substrate: | 0.081 |
CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.156 |
CYP3A4-inhibitor: | 0.088 | CYP3A4-substrate: | 0.844 |
Clearance (CL): | 1.128 | Half-life (T1/2): | 0.044 |
hERG Blockers: | 0.008 | Human Hepatotoxicity (H-HT): | 0.019 |
Drug-inuced Liver Injury (DILI): | 0.016 | AMES Toxicity: | 0.114 |
Rat Oral Acute Toxicity: | 0.557 | Maximum Recommended Daily Dose: | 0.436 |
Skin Sensitization: | 0.034 | Carcinogencity: | 0.063 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
Respiratory Toxicity: | 0.918 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005707 | 0.667 | D0G8OC | 0.407 | ||||
ENC001092 | 0.667 | D0G5CF | 0.391 | ||||
ENC004738 | 0.667 | D06JPB | 0.377 | ||||
ENC001889 | 0.652 | D04RYU | 0.348 | ||||
ENC005258 | 0.638 | D0Y7LD | 0.331 | ||||
ENC005238 | 0.595 | D0M2QH | 0.329 | ||||
ENC001769 | 0.559 | D0S0NK | 0.325 | ||||
ENC002892 | 0.540 | D0N1TP | 0.324 | ||||
ENC005270 | 0.536 | D07ORO | 0.322 | ||||
ENC001984 | 0.516 | D01QUS | 0.313 |